Fig. 4From: Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancerKaplan–Meier survival analysis based on a combined biomarker set (BCAT1 and CD133). Disease-free survival (a) and overall survival (b) in double-low-expression, mixed-expression, and double-high-expression groups. *P < 0.05, ***P < 0.001Back to article page